BIOSAFE LICENSES AUTOTRANSFUSION TECHNOLOGY TO JOSTRA.In a move to further broaden its extensive portfolio of open heart surgery equipment, JOSTRA has obtained an exclusive worldwide license for exploiting a new autotransfusion technology developed by BIOSAFE.Autotransfusion is a technique whereby the blood of a patient is recovered, washed and reinfused, avoiding disease transmission like hepatitis and AIDS. The system will be commercialized by JOSTRA under the trademark RotaCell .The potential autotransfusion market represents a value of 300 M$. Financial terms of the transaction were not disclosed. The technology developed by Biosafe offers unique advantages, such as the possibility to treat any amount of blood due to its variable separation chamber. It allows recovery of highly concentrated washed red cells washed red cells Transfusion medicine RBCs that have been washed in sterile saline to remove WBCs, lytic mediators, non-self antigens; WRCs are most useful in IgA-deficient Pts who have circulating anti-IgA antibodies, used to ↓ febrile, urticarial and even in cases of low blood loss. Indications cover all types of surgery including cardiac and orthopaedic, and can be extended to postoperative blood recovery. The RotaCell system is also ideally suited for all paediatric Adj. 1. paediatric - of or relating to the medical care of children; "pediatric dentist" pediatric surgery. Compact, portable and very easy to use, the system is also ideal for mobile services. "The addition of RotaCell to our range of equipment for extracorporeal circulation extracorporeal circulation n. Circulation of the blood outside the body, as through a heart-lung machine or artificial kidney. reinforces our commitment to deliver a full line of effective devices for open heart surgery," said Christian Palme Pal·me , Olaf 1927-1986. Swedish politician. As premier (1969-1976 and 1982-1986) he was widely respected for his efforts toward peace and disarmament. Palme was assassinated in 1986. , CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. of JOSTRA AG. "With the recent acquisition of BENTLEY, we now reach an extensive network of cardiac surgeons and anaesthetists. The RotaCell technology will allow us to enter new markets like intensive care as well." "We are pleased to have concluded this licensing agreement with a company of such high reputation as JOSTRA," said Claude Fell, founder and CEO of BIOSAFE SA. "Although our technology offers a wide platform of applications, BIOSAFE's strategy is to focus on its core business, cell therapy, and license its technology for other markets. We believe JOSTRA is ideally placed to promote this new blood salvage system in autotransfusion applications." The RotaCell system will be available for commercialization by the end of 2001. About JOSTRA AG JOSTRA AG was established in December 1982 by Lars Sunnanvader, who today holds the position as chairman of JOSTRA's supervisory board Supervisory board The board of directors that represents stakeholders in the governance of the corporation. . His guiding principle "To do the right thing at the right time, because life is too precious for wrong decisions." was adopted as the company philosophy. In less than 15 years, the company became the only manufacturer with its home office in Germany offering a complete line of medical technology devices and heart-lung machines for open heart surgery. Jostra runs three production facilities in Hechingen/Hirrlingen (Germany), one in Lund (Sweden) and one in Anasco (Puerto Rico). The company headquarter head·quar·ter v. head·quar·tered, head·quar·ter·ing, head·quar·ters Usage Problem v.tr. To provide with headquarters: are in Hirrlingen, Germany, near the city of Stuttgart. In addition, there are six subsidiaries in Sweden, France, Italy, Japan, the U.S. and China as well as four sales offices in Norway, the Netherlands, Spain and Great Britain. Today, Jostra delivers its products to more than 80 countries. The product range includes heart-lung machines, hypo-hyperthermia units, membrane oxygenators, reservoirs, catheters and cannulaes, custom tubing packs, blood concentrators, centrifugal pumps and coating systems. Jostra is internationally renowned for the high quality and the safety of its products. In Europe, Jostra holds a market share of more than 30 per cent in the field of heart lung machines, making it the undisputed market leader. Also in the field of oxygenators, the company is among the market leaders with a share of 20 per cent. About BIOSAFE SA BIOSAFE SA is a start-up company start-up company A new business. founded in 1997, with objectives to develop and commercialise innovative cell separation systems. Applications range from blood component separations for blood banking, to the collection of stem cells stem cells, unspecialized human or animal cells that can produce mature specialized body cells and at the same time replicate themselves. Embryonic stem cells are derived from a blastocyst (the blastula typical of placental mammals; see embryo), which is very young in cell therapy. The company recently introduced the SEPAXtm system, a portable cell separator with ability to recover stem cells from bone marrow, peripheral or umbilical cord blood umbilical cord blood Transplantation A source of primitive and stem cells that can be used to reconstitute BM destroyed by aplastic anemia or by RT or chemotherapy for CA, lymphoproliferative malignancies. See Bone marrow transplantation, Stem cell therapy. . The company has offices in Eysins, near Geneva Geneva, canton and city, Switzerland Geneva (jənē`və), Fr. Genève, canton (1990 pop. 373,019), 109 sq mi (282 sq km), SW Switzerland, surrounding the southwest tip of the Lake of Geneva. , Switzerland and operates through a network of distributors. For more information, fax. +41-22-361 70 51 or e-mail to claude.fell@biosafe.ch |
|
||||||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion